| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/1099800403005001006 Impact of Sex and Gender on Irritable Bowel Syndromeheit{at}u.washington.edu
Department of Biobehavioral Nursing & Health Systems, University of Washington, Seattle.
Department of Medicine at the University of California, Los Angeles. Irritable bowel syndrome (IBS) is a common functional bowel disorder characterized by abdominal pain and change in defecation pattern. This review addresses the topic of possible sex (genetic, biological) and gender (experiential, perceptual) differences in individuals with and without IBS. Several observations make the topic important. First, there is a predominance of women as compared to men who seek health care services for IBS in the United States and other industrialized societies. Second, menstrual cycle-linked differences are observed in IBS symptom reports. Third, women with IBS tend to report greater problems with constipation and nongastrointestinal complaints associated with IBS. Fourth, serotonin (5-HT3) receptor antagonist and 5-HT4 partial agonist drugs appear to more effectively diminish reports of bowel pattern disruption in women with IBS as compared to men. This review examines sex and gender modulation of gastrointestinal motility and transit, visceral pain sensitivity, autonomic nervous system function, serotonin biochemistry, and differences in health care-seeking behavior for IBS.
Key Words: estrogen women's health gender gastrointestinal trial irritable bowel syndrome stress
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||



